
The Analyst:
Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC:CRLBF) as Overweight with a price target of $19.00.

Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC:CRLBF) as Overweight with a price target of $19.00.